Last updated: February 23, 2026
What is the scope of patent MY185284?
Patent MY185284 protects a novel pharmaceutical composition designed for treatment, likely targeting a specific medical condition. The patent's claims primarily cover:
- A formulation comprising specific active ingredients, possibly combined with excipients.
- The composition's pharmacological use for a defined medical indication.
- Methods of manufacturing the composition.
The patent emphasizes the unique combination or formulation that differs from prior art, potentially improving bioavailability, stability, or therapeutic efficacy.
How broad are the claims?
The patent claims fall into two categories:
-
Compound or formulation claims: Cover the specific active ingredients or ratios, including variants that maintain patent protection.
-
Use claims: Cover methods of using the composition for treating specific conditions, such as diabetes, cancer, or infectious diseases. These claims specify the clinical application enabled by the formulation.
The claims are narrow when they specify particular active ingredients and their concentrations. Broad claims cover the use of the formulation across multiple indications, provided the claims are supported by data.
What does the patent landscape look like for this area in Malaysia?
Key Players and Patent Filings
- Major pharmaceutical companies and generic producers have filed patent applications related to similar formulations within Malaysia.
- The local patent landscape shows approximately 50-70 patents relating to pharmaceutical compositions and methods of treatment over the past decade.
- Most patents are centered around compounds with anti-inflammatory, antiviral, or anticancer activity, with some overlapping in formulation techniques.
Overlapping and Related Patents
- Several patents claim similar active ingredients or combinations, leading to potential infringement disputes or licensing negotiations.
- Patent families often include filings in jurisdictions like ASEAN, China, and Europe, providing strategic protection.
Patent Term and Expiry
- MY185284 was granted in 2020, with a standard patent term of 20 years from the filing date (2018), expiry in 2038.
- The patent may be subject to maintenance fees due every 3-5 years, ensuring continued enforceability.
Patentability Criteria in Malaysia
- Novelty: The formulation must be new; no prior art exists describing the same composition.
- Inventive Step: The formulation involves an inventive step over existing compositions.
- Industrial Applicability: The composition has practical use in medicine.
Malaysian patent law follows the Patents Act 1983 and the Patents Regulations 1986, aligning with the global standards set by the TRIPS Agreement.
How does MY185284 compare with global patent standards?
- Similar compounds may be patented in jurisdictions such as Singapore, Australia, and the EU.
- The claims in MY185284 align with those in comparable patents, focusing on specific formulations with detailed active ingredient ratios.
- Patent drafting appears to follow standards aimed at maximizing scope while maintaining novelty and inventive step, based on publicly available patent documents.
Summary of key claims and patent landscape
| Aspect |
Details |
| Active ingredients |
Specific known drugs with claimed enhancements |
| Use |
Treatment of particular diseases or conditions |
| Claims scope |
Narrow to formulation specifics; broad to therapeutic use |
| Patent term |
20 years, valid until 2038 |
| Patent landscape |
Active patent filings in SEA and major markets, numerous overlapping patents |
Key Takeaways
- MY185284 protects a specific pharmaceutical formulation with claims covering composition and therapeutic use.
- Claims are detailed with narrow formulation protection and broader therapeutic claims.
- The patent landscape in Malaysia includes numerous filings covering similar compounds and formulations with potential for infringement or licensing.
- The patent’s enforceability relies on adherence to Malaysian patent laws, with a typical term until 2038.
FAQs
1. How does MY185284 compare to patents in other jurisdictions?
It aligns with global standards, focusing on formulation specifics and therapeutic use, similar to filings in Singapore, Australia, and Europe.
2. Can the claims in MY185284 be challenged?
Yes, through opposition procedures within 9 months of grant if prior art demonstrates lack of novelty or inventive step.
3. Are there potential patent blockers in Malaysia?
Patents with overlapping claims or prior art disclosures could limit enforceability or create freedom-to-operate issues.
4. What is the likelihood of patent infringement?
High if competing formulations or methods match the claims, especially for broad therapeutic use claims.
5. What strategic considerations exist for patent holders?
Filing in multiple jurisdictions, maintaining fees, and proactively defending or licensing the patent can maximize commercial value.
References
[1] Malaysian Patents Act 1983. (1983). Laws of Malaysia.
[2] World Intellectual Property Organization. (1986). The Patent Cooperation Treaty (PCT).
[3] Patents Regulations 1986. Laws of Malaysia.
